225 related articles for article (PubMed ID: 22851705)
1. The role of properdin in zymosan- and Escherichia coli-induced complement activation.
Harboe M; Garred P; Lindstad JK; Pharo A; Müller F; Stahl GL; Lambris JD; Mollnes TE
J Immunol; 2012 Sep; 189(5):2606-13. PubMed ID: 22851705
[TBL] [Abstract][Full Text] [Related]
2. Properdin binding to complement activating surfaces depends on initial C3b deposition.
Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958
[TBL] [Abstract][Full Text] [Related]
3. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding.
Brouwer N; Dolman KM; van Houdt M; Sta M; Roos D; Kuijpers TW
J Immunol; 2008 Mar; 180(6):4124-32. PubMed ID: 18322223
[TBL] [Abstract][Full Text] [Related]
4. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.
Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM
mBio; 2011; 2(5):. PubMed ID: 21878570
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.
Agarwal S; Ferreira VP; Cortes C; Pangburn MK; Rice PA; Ram S
J Immunol; 2010 Jul; 185(1):507-16. PubMed ID: 20530262
[TBL] [Abstract][Full Text] [Related]
6. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.
Spitzer D; Mitchell LM; Atkinson JP; Hourcade DE
J Immunol; 2007 Aug; 179(4):2600-8. PubMed ID: 17675523
[TBL] [Abstract][Full Text] [Related]
7. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop.
Brouwer N; Dolman KM; van Zwieten R; Nieuwenhuys E; Hart M; Aarden LA; Roos D; Kuijpers TW
Mol Immunol; 2006 May; 43(13):2051-60. PubMed ID: 16499969
[TBL] [Abstract][Full Text] [Related]
8. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement.
Zhang J; Song L; Pedersen DV; Li A; Lambris JD; Andersen GR; Mollnes TE; Ma YJ; Garred P
Elife; 2020 Sep; 9():. PubMed ID: 32909942
[TBL] [Abstract][Full Text] [Related]
9. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.
Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG
Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133
[TBL] [Abstract][Full Text] [Related]
10. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
Des Prez RM; Bryan CS; Hawiger J; Colley DG
Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
[TBL] [Abstract][Full Text] [Related]
11. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.
Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J
Front Immunol; 2020; 11():1643. PubMed ID: 32849563
[No Abstract] [Full Text] [Related]
12. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
DiScipio RG
Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
[TBL] [Abstract][Full Text] [Related]
13. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
Brade V; Bentley C; Bitter-Suermann D; Hadding U
Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
[TBL] [Abstract][Full Text] [Related]
14. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1.
Stoiber H; Schneider R; Janatova J; Dierich MP
Immunobiology; 1995 Jun; 193(1):98-113. PubMed ID: 7590866
[TBL] [Abstract][Full Text] [Related]
15. Complement activation by tubular cells is mediated by properdin binding.
Gaarkeuken H; Siezenga MA; Zuidwijk K; van Kooten C; Rabelink TJ; Daha MR; Berger SP
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1397-403. PubMed ID: 18753294
[TBL] [Abstract][Full Text] [Related]
16. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).
Saggu G; Cortes C; Emch HN; Ramirez G; Worth RG; Ferreira VP
J Immunol; 2013 Jun; 190(12):6457-67. PubMed ID: 23677468
[TBL] [Abstract][Full Text] [Related]
18. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
Vuagnat BB; Mach J; Le Doussal JM
Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterisation of the thrombospondin type I repeats of human properdin.
Perdikoulis MV; Kishore U; Reid KB
Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971
[TBL] [Abstract][Full Text] [Related]
20. Association of activated properdin with complexes of properdin with C3.
Whiteman LY; Purkall DB; Ruddy S
J Immunol; 1991 Aug; 147(4):1344-51. PubMed ID: 1869827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
